Jul 13, 2026 08:31AM
Jul 13, 2026 08:30AM
Jun 2, 2026 04:05PM
Jun 2, 2026 04:05PM
May 14, 2026 04:09PM
May 14, 2026 04:07PM
Apr 30, 2026 04:15PM Cue Biopharma licenses anti-IgE antibody in $691.5 million deal
Apr 30, 2026 04:15PM
Apr 30, 2026 04:07PM
Apr 30, 2026 04:05PM
Apr 22, 2026 08:37AM
Apr 22, 2026 08:37AM
Apr 15, 2026 08:01AM
Apr 15, 2026 08:00AM Cue Biopharma to Present New Preclinical Data on Lead Autoimmune and Inflammatory Disease Candidate CUE-401 at IMMUNOLOGY2026
Apr 8, 2026 08:00AM
Apr 8, 2026 08:00AM
Mar 27, 2026 04:05PM
Mar 27, 2026 04:05PM
Mar 26, 2026 08:00AM
Mar 16, 2026 04:05PM
Mar 9, 2026 08:00AM Cue Biopharma to Present New In vitro Data for CUE-401 at the 20th World Immune Regulation Meeting (WIRM) 2026
Feb 17, 2026 08:00AM
Feb 12, 2026 08:02AM
Feb 12, 2026 08:00AM
Nov 12, 2025 04:05PM
Nov 6, 2025 08:02AM
Nov 6, 2025 08:00AM
Sep 29, 2025 09:00AM Cue Biopharma names Usman Azam as new CEO effective September 29
Sep 29, 2025 09:00AM
Aug 13, 2025 08:00AM
Aug 12, 2025 04:05PM
Jul 16, 2025 08:00AM
Jul 16, 2025 08:00AM
Jul 1, 2025 04:05PM
Jul 1, 2025 04:05PM Cue Biopharma Provides Update on Most Advanced Clinical Stage Asset, CUE-101, Presented by Dr. Dimitrios Colevas at the DAVA 4th Hawaii Global Summit on Thoracic Malignancies
Jun 24, 2025 04:48PM
Jun 24, 2025 04:48PM
May 12, 2025 04:05PM
May 8, 2025 08:00AM
Apr 14, 2025 05:00PM
Apr 14, 2025 05:00PM
Mar 31, 2025 04:20PM Cue Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
Nov 14, 2024 04:05PM
Nov 14, 2024 08:00AM
Nov 8, 2024 01:31PM
Nov 8, 2024 01:30PM
Sep 9, 2024 08:03AM
Sep 9, 2024 08:00AM
Sep 3, 2024 08:00AM Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference
Aug 19, 2024 04:05PM

326,541 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All